Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study.

Wunder C, Persu A, Lengelé JP, Mg Georges C, Renkin J, Pasquet A, Carlier M, Zhang ZY, Staessen JA; European Network Coordinating Research on Renal Denervation (ENCOReD), Stefan W. Toennes.

Blood Press. 2019 Jun;28(3):168-172. doi: 10.1080/08037051.2019.1599814. Epub 2019 Apr 3.

PMID:
30942111
2.

Fanconi Syndrome in Alcoholic Patients: Old Concept, New Idea.

Werion A, Lengelé JP.

Nephron. 2019;141(3):201-202. doi: 10.1159/000496035. Epub 2019 Jan 2. No abstract available.

PMID:
30602151
3.

Genomics of Fibromuscular Dysplasia.

Di Monaco S, Georges A, Lengelé JP, Vikkula M, Persu A.

Int J Mol Sci. 2018 May 21;19(5). pii: E1526. doi: 10.3390/ijms19051526. Review.

4.

Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis.

Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D.

J Clin Microbiol. 2018 May 25;56(6). pii: e00002-18. doi: 10.1128/JCM.00002-18. Print 2018 Jun.

5.

Renal infarction management: towards an etiological approach?

Lengelé JP, Christophe JL, Persu A.

J Hypertens. 2018 Mar;36(3):490-492. doi: 10.1097/HJH.0000000000001629. No abstract available.

PMID:
29384986
6.

Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.

Jacobs L, Persu A, Huang QF, Lengelé JP, Thijs L, Hammer F, Yang WY, Zhang ZY, Renkin J, Sinnaeve P, Wei FF, Pasquet A, Fadl Elmula FEM, Carlier M, Elvan A, Wunder C, Kjeldsen SE, Toennes SW, Janssens S, Verhamme P, Staessen JA; European Network Coordinating Research on Renal Denervation.

Blood Press. 2017 Dec;26(6):321-331. doi: 10.1080/08037051.2017.1320939. Epub 2017 May 10.

PMID:
28489464
7.

Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Van der Niepen P, Rossignol P, Lengelé JP, Berra E, Sarafidis P, Persu A.

Curr Hypertens Rep. 2017 Jan;19(1):5. doi: 10.1007/s11906-017-0703-8. Review.

PMID:
28150134
8.

Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule.

Terryn S, Tanaka K, Lengelé JP, Olinger E, Dubois-Laforgue D, Garbay S, Kozyraki R, Van Der Smissen P, Christensen EI, Courtoy PJ, Bellanné-Chantelot C, Timsit J, Pontoglio M, Devuyst O.

Kidney Int. 2016 May;89(5):1075-1089. doi: 10.1016/j.kint.2016.01.027. Epub 2016 Mar 29.

PMID:
27083284
9.

Alcohol-induced hypertension: an important healthcare target in Belgium.

Collart F, de Timary P, Dom G, Dor BD, Duprez D, Lengelé JP, Matthys F, Peuskens H, Rehm J, Stärkel P.

Acta Clin Belg. 2015 Dec;70(6):389-95. doi: 10.1179/2295333715Y.0000000039. Epub 2015 Jul 2. Review.

PMID:
26135944
10.

Con: renal denervation for all resistant hypertensive patients: the Emperor's new clothes.

Persu A, Jin Y, Lengelé JP, Jacobs L, Renkin J, Staessen JA.

Nephrol Dial Transplant. 2014 Jun;29(6):1116-9. doi: 10.1093/ndt/gfu098. No abstract available.

11.

Denervation of native kidneys in a renal transplant recipient: one swallow does not make a spring.

Persu A, Lengelé JP, Jin Y, Kanaan N, Staessen JA.

Am J Hypertens. 2014 Jul;27(7):897-8. doi: 10.1093/ajh/hpu075. Epub 2014 May 2. No abstract available.

PMID:
24795400
12.

Rationale and design of the Investigator-Steered Project on Intravascular Renal Denervation for Management of Drug-Resistant Hypertension (INSPiRED) trial.

Jin Y, Jacobs L, Baelen M, Thijs L, Renkin J, Hammer F, Kefer J, Petit T, Verhamme P, Janssens S, Sinnaeve P, Lengelé JP, Persu A, Staessen JA; investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPiRED) investigators.

Blood Press. 2014 Jun;23(3):138-46. doi: 10.3109/08037051.2014.899297. Epub 2014 Apr 17.

13.

Expression of renal cystic genes in patients with HNF1B mutations.

Faguer S, Decramer S, Devuyst O, Lengelé JP, Fournié GJ, Chauveau D.

Nephron Clin Pract. 2012;120(2):c71-8. doi: 10.1159/000334954. Epub 2012 Jan 21.

14.

Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood.

Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D.

Kidney Int. 2011 Oct;80(7):768-76. doi: 10.1038/ki.2011.225. Epub 2011 Jul 20.

15.

Discrepancy between European Society of Hypertension and SCORE risk assessment methods in hypertensive patients: still a matter of concern--answer to Sehestedt et al.

Lengelé JP, D'Hoore W, Persu A.

J Hypertens. 2010 Oct;28(10):2171-3; author reply 2173-5. doi: 10.1097/HJH.0b013e32833ee977. No abstract available.

PMID:
20844374
16.

Periodic paralyses: when channels go wrong.

Lengelé JP, Belge H, Devuyst O.

Nephrol Dial Transplant. 2008 Apr;23(4):1098-101. doi: 10.1093/ndt/gfn011. Epub 2008 Feb 16. No abstract available.

PMID:
18281721
17.

Cardiovascular risk assessment in hypertensive patients: major discrepancy according to ESH and SCORE strategies.

Lengelé JP, Vinck WJ, De Plaen JF, Persu A.

J Hypertens. 2007 Apr;25(4):757-62.

PMID:
17351366

Supplemental Content

Loading ...
Support Center